机译:BET溴结构域蛋白在去势抵抗性前列腺癌中的治疗靶向
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia 30329, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia 30329, USA;
Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA,Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA;
机译:靶向溴琼肿瘤和终端(BET)家族蛋白在阉割的前列腺癌(CRPC)中
机译:CBP / P300 Bromodomain的治疗靶向阻断抗阉割前列腺癌的生长
机译:靶向BRD4-HOXB13的Coregulated转录网络,具有溴琼酶 - 激酶抑制剂,以抑制转移性阉割的前列腺癌
机译:抗阉割前列腺癌:新型靶点,药剂和试验
机译:Bet蛋白在抗阉割前列腺癌传播中的作用
机译:BET溴结构域蛋白在去势抵抗性前列腺癌中的治疗靶向
机译:靶向溴琼肿瘤和终端(BET)家族蛋白在阉割的前列腺癌(CRPC)中